Survival outcomes for various treatment modalities in advanced-stage grade 3 follicular lymphoma (FL3): A National Cancer Database (NCDB) study.

被引：0
|
作者：
Giri, Upama
Vick, Eric
Lee, Sophia SeoHyeon
Altahan, Alaa
VanderWalde, Noam Avraham
Dickson, Paxton Vandiver
Deneve, Jeremiah Lee
Martin, Michael Gary
机构：
[1] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA
[2] Univ Tennessee, Dept Radiat Oncol, West Canc Ctr, Hlth Sci Ctr, Memphis, TN 38163 USA
[3] Univ Tennessee, Div Surg Oncol, Dept Surg, West Canc Ctr,Hlth Sci Ctr, Memphis, TN 38163 USA
[4] Univ Tennessee, Dept Hematol Oncol, West Canc Ctr, Hlth Sci Ctr, Memphis, TN 38163 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.7554
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7554
引用
收藏
页数：6
相关论文
共 39 条
  • [31] Front - Line combined immuno-chemotherapy (R-CHOP) significantly improves the time to treatment failure and overall survival in elderly patients with advanced stage follicular lymphoma - Results of a prospective randomized trial of the German low grade lymphoma study group (GLSG).
    Buske, Christian
    Kneba, Michael
    Lengfelder, Eva
    Pfreundschuh, Michael
    Ludwig, Wolf-Dieter
    Graeven, Ullrich
    Hallek, Michael
    Dreyling, Martin
    Unterhalt, Michael
    Hiddemann, Wolfgang
    BLOOD, 2006, 108 (11) : 146A - 147A
  • [32] Treatment Reduction in Patients with Advanced-Stage Hodgkin Lymphoma and Negative Interim FDG-PET: Final Results of the International, Randomized, Phase 3 HD18 Trial by the German Hodgkin Study Group
    Kobe, C.
    Goergen, H.
    Fuchs, M.
    Eich, H. T.
    Baues, C.
    Diehl, V.
    Kuhnert, G.
    Drzezga, A.
    Dietlein, M.
    Engert, A.
    Borchmann, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S312 - S312
  • [33] Patterns of use of 18-fluoro-2-deoxy-D-glucose positron emission tomography for initial staging of grade 1-2 follicular lymphoma and its impact on initial treatment strategy in the National Comprehensive Cancer Network Non-Hodgkin Lymphoma Outcomes database
    Abou-Nassar, Karim E.
    Vanderplas, Ann
    Friedberg, Jonathan W.
    Abel, Gregory A.
    Niland, Joyce
    Rodriguez, Maria A.
    Czuczman, Myron S.
    Millenson, Michael
    Crosby, Allison
    Gordon, Leo I.
    Zelenetz, Andrew D.
    Kaminski, Mark
    Lacasce, Ann S.
    LEUKEMIA & LYMPHOMA, 2013, 54 (10) : 2155 - 2162
  • [34] Results of Laparoscopic Surgery and D3 Lymph Node Dissection Combined With Chemotherapy for the Radical Treatment of Advanced-Stage Right Colon Cancer: A Single-Center Observational Study in Vietnam
    Thanh, Long Huynh
    Manh, Khiem Nguyen
    Thi, Minh Nguyen
    Trung, Anh Nguyen Tri
    Trung, Kien Nguyen
    Le Viet, Thang
    Huy, Nung Vu
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
  • [35] PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group
    Borchmann, Peter
    Goergen, Helen
    Kobe, Carsten
    Lohri, Andreas
    Greil, Richard
    Eichenauer, Dennis A.
    Zijlstra, Josee M.
    Markova, Jana
    Meissner, Julia
    Feuring-Buske, Michaela
    Huttmann, Andreas
    Dierlamm, Judith
    Soekler, Martin
    Beck, Hans-Joachim
    Willenbacher, Wolfgang
    Ludwig, Wolf-Dieter
    Pabst, Thomas
    Topp, Max S.
    Hitz, Felicitas
    Bentz, Martin
    Keller, Ulrich Bernd
    Kuhnhardt, Dagmar
    Ostermann, Helmut
    Schmitz, Norbert
    Hertenstein, Bernd
    Aulitzky, Walter
    Maschmeyer, Georg
    Vieler, Tom
    Eich, Hans
    Baues, Christian
    Stein, Harald
    Fuchs, Michael
    Kuhnert, Georg
    Diehl, Volker
    Dietlein, Markus
    Engert, Andreas
    LANCET, 2017, 390 (10114): : 2790 - 2802
  • [36] Non-Private Health Insurance Predicts Advanced Stage at Presentation and Amputation in Lower Extremity High Grade Bone Sarcoma: A National Cancer Database Study Amputation Predicts Survival: An Effect Most Pronounced in Pediatric and AYA Age Group
    Jawad, Muhammad Umar
    Pollock, Brad H.
    Alvarez, Elysia
    Carr-Ascher, Janai R.
    Randall, R. Lor
    Thorpe, Steven W.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (07) : 4363 - 4372
  • [37] CLINICAL OUTCOMES AND TREATMENT PLANNING STRATEGIES FOR ADVANCED-STAGE NON-SMALL CELL LUNG CANCER (NSCLC) TREATED BY INTENSITY MODULATED RADIATION THERAPY (IMRT) OR 3DIMENTIONAL CONFORMAL RADIATION THERAPY (3DCRT) WITH CONCURRENT CHEMOTHERAPY (CCT)
    Komaki, R.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S28 - S29
  • [38] Exon-Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B-Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study.
    Koivula, Satu
    Taskinen, Minna
    Chen, Ping
    Holte, Harald
    Delabie, Jan
    Karjalainen-Lindsberg, Marja-Liisa
    Bjorkholm, Magnus
    Fluge, Oystein
    Pedersen, Lars Moller
    Jerkeman, Mats
    Eriksson, Mikael
    Hautaniemi, Sampsa
    Leppa, Sirpa
    BLOOD, 2010, 116 (21) : 1281 - 1281
  • [39] Serplulimab vs. placebo combined with chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: Extended follow-up results and patient-reported outcomes from the international phase 3 ASTRUM-005 study.
    Cheng, Ying
    Han, Liang
    Wu, Lin
    Chen, Jun
    Sun, Hongmei
    Wen, Guilan
    Ji, Yinghua
    Zimina, Anastasia V.
    Shi, Jianhua
    Pan, Zhijie
    Shi, Jinsheng
    Wang, Xicheng
    Bai, Yuansong
    Melkadze, Tamar
    Pan, Yueyin
    Min, Xuhong
    Viguro, Maksym
    Li, Jing
    Wang, Qingyu
    Zhu, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
1234